MBX Biosciences director granted 12,500 stock options
MBX Biosciences director Steven Ryder received a grant of stock options covering 12,500 shares of common stock.
Rhea-AI Filing Summary
MBX Biosciences director Steven Ryder received a grant of stock options covering 12,500 shares of common stock. The options have an exercise price of $30.91 per share and were awarded at no cost as a compensation grant.
The award vests in full on the earlier of the one-year anniversary of the grant date or the company’s next annual stockholder meeting, as long as Ryder continues serving as a non-employee director. After this grant, he holds options for 12,500 underlying shares, which expire on June 4, 2036.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 12,500 shares
Grant/Award
1 txn
Insider
Ryder Steven
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock option (right to buy) | 12,500 | $0.00 | $0.00 |
Holdings After Transaction:
Stock option (right to buy) — 12,500 contracts (Direct)
Footnotes (1)
- F1. The grant will vest in full on the earlier of the one-year anniversary of the grant date or on the date of our next annual meeting of stockholders, subject to the non-employee director's continued services to the Company.
Key Figures
Options granted: 12,500 options
Exercise price: $30.91 per share
Expiration date: June 4, 2036
+2 more
5 metrics
Options granted
12,500 options
Stock option grant to director Steven Ryder
Exercise price
$30.91 per share
Strike price of stock options
Expiration date
June 4, 2036
Option expiration
Shares underlying options
12,500 shares
Common stock underlying granted options
Cost of grant
$0.00
Award granted at no upfront cost to director
Key Terms
Stock option (right to buy), exercise price, expiration date, underlying security, +1 more
5 terms
Stock option (right to buy) financial
"security_title: Stock option (right to buy)"
exercise price financial
"conversion_or_exercise_price: 30.9100"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-06-04T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
underlying security financial
"underlying_security_title: Common Stock"
non-employee director financial
"subject to the non-employee director's continued services to the Company"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did MBX director Steven Ryder report in this Form 4?
Steven Ryder reported receiving a grant of stock options for 12,500 shares of MBX Biosciences common stock. These options were awarded as compensation, with an exercise price of $30.91 per share and no cash paid upfront for the grant itself.
What is the exercise price of Steven Ryder’s MBX stock options?
The stock options granted to Steven Ryder have an exercise price of $30.91 per share. This is the fixed price he would pay per share to convert the options into common stock before their stated expiration date in June 2036.
When do Steven Ryder’s MBX stock options vest?
Ryder’s options vest in full on the earlier of one year from the grant date or the next MBX annual stockholder meeting. Vesting is conditioned on his continued service as a non-employee director through that applicable vesting date.
When do Steven Ryder’s MBX stock options expire?
The stock options granted to Steven Ryder expire on June 4, 2036. He may exercise them at $30.91 per share any time after vesting and before that expiration date, subject to the terms of the company’s equity plan and award agreement.
AI-generated analysis. How Rhea-AI works. Not financial advice.
